Association Between Polymorphisms at N-acetyltransferase 1 (NAT1) & Risk of Oral Leukoplakia & Cancer

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2012 Nov 22

PMID 23168701

Citations 9

Authors

Mousumi Majumder

Saurabh Ghosh

Bidyut Roy

Affiliations

Soon will be listed here.

Abstract

Background & Objectives: N-acetyltransferases 1 and 2 (NAT1 and NAT2) are important enzymes for metabolism of tobacco carcinogens. Due to polymorphisms, improper activities of these enzymes might lead to the formation of DNA adducts that may modulate risk of tobacco related oral precancer and cancer. Previously, it was shown that NAT2 polymorphisms did not modulate the risk of oral precancer and cancer. We undertook this study to check whether polymorphisms at NAT1 can modulate the risk of oral leukoplakia and cancer either alone or in combination with NAT2.

Methods: Genotypes at four SNPs on NAT1 were determined by TaqMan method in 389 controls, 224 leukoplakia and 310 cancer patients. Genotype data were analyzed to know haplotypes and acetylation status of individuals and, then to estimate the risk of diseases. Using our previously published NAT2 data, combination of NAT1 and NAT2 acetylation genotypes of patients and controls were also analyzed to estimate the risk of diseases.

Results: Analysis of NAT1 genotype data revealed that 1088T and 1095C alleles exist in strong linkage disequilibrium (r 2 =0.97, P<0.0001) and SNPs are in Hardy-Weinberg Equilibrium (P=0.1). Wild type or normal acetylating and variant or rapid acetylating alleles were two major alleles (frequencies 0.62 and 0.36, respectively) present in the control population. NAT1 rapid acetylation could not modulate the risk of leukoplakia and cancer (OR=0.9, 95% CI: 0.6-1.3; OR=1.0, 95% CI: 0.7-1.4, respectively). Analysis of combined NAT1 and NAT2 acetylating data also showed no significant enhancement of the risk of diseases.

Interpretation & Conclusions: NAT1 rapid acetylation alone as well as combination of NAT1 rapid-NAT2 slow acetylation did not modulate the risk of oral precancer and cancer in our patient population. So, NAT1/NAT2 metabolized carcinogen products may not be involved in tobacco related oral precancer and cancer. It may be interpreted that large sample size as well as combination of polymorphisms at other candidate loci may be important to estimate the risk of a complex disease like oral cancer.

Citing Articles

Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population.

Gogolewska M, Kabzinski J, Majsterek I Int J Occup Med Environ Health. 2023; 36(6):812-824.

PMID: 38099560 PMC: 10743347. DOI: 10.13075/ijomeh.1896.02070.

Effect of ALA-PDT on inhibition of oral precancerous cell growth and its related mechanisms.

Jin J, Wang Q, Zhang Y, Wang X, Lu Z, Li B Lasers Med Sci. 2022; 37(9):3461-3472.

PMID: 35796919 DOI: 10.1007/s10103-022-03607-y.

Association of Polymorphisms with Susceptibility to Head and Neck Cancers-A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis.

Mohammadi H, Momeni Roochi M, Sadeghi M, Garajei A, Heidar H, Ghaderi B Medicina (Kaunas). 2021; 57(10).

PMID: 34684132 PMC: 8541135. DOI: 10.3390/medicina57101095.

Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: Review of evidence to date.

Shridhar K, Aggarwal A, Walia G, Gulati S, Geetha A, Prabhakaran D Oral Oncol. 2016; 61:146-51.

PMID: 27688118 PMC: 5046699. DOI: 10.1016/j.oraloncology.2016.08.005.

Genotypic distribution of single nucleotide polymorphisms in oral cancer: global scene.

Multani S, Saranath D Tumour Biol. 2016; 37(11):14501-14512.

PMID: 27651159 DOI: 10.1007/s13277-016-5322-5.

References

Sikdar N, Mahmud S, Paul R, Roy B . Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett. 2003; 195(1):33-42. DOI: 10.1016/s0304-3835(03)00156-3. View

Gupta P, MEHTA F, Daftary D, PINDBORG J, Bhonsle R, Jalnawalla P . Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol. 1980; 8(6):283-333. DOI: 10.1111/j.1600-0528.1980.tb01302.x. View

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

Agundez J . Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab. 2008; 9(6):520-31. DOI: 10.2174/138920008784892083. View

Olshan A, Weissler M, Watson M, Bell D . GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2000; 9(2):185-91. View

Katoh T, Kaneko S, BOISSY R, Watson M, Ikemura K, Bell D . A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Carcinogenesis. 1998; 19(10):1803-7. DOI: 10.1093/carcin/19.10.1803. View

Anantharaman D, Chaubal P, Kannan S, Bhisey R, Mahimkar M . Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. 2007; 28(7):1455-62. DOI: 10.1093/carcin/bgm038. View

Lubin J, Caporaso N . Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev. 2006; 15(3):517-23. DOI: 10.1158/1055-9965.EPI-05-0863. View

Butcher N, Boukouvala S, Sim E, Minchin R . Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J. 2002; 2(1):30-42. DOI: 10.1038/sj.tpj.6500053. View

10.

Anantharaman D, Samant T, Sen S, Mahimkar M . Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncol. 2011; 47(9):866-72. DOI: 10.1016/j.oraloncology.2011.06.015. View

11.

Demokan S, Suoglu Y, Gozeler M, Demir D, Dalay N . N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer. Mol Biol Rep. 2009; 37(7):3217-26. DOI: 10.1007/s11033-009-9905-8. View

12.

Majumder M, Sikdar N, Paul R, Roy B . Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280). Cancer Epidemiol Biomarkers Prev. 2005; 14(9):2106-12. DOI: 10.1158/1055-9965.EPI-05-0108. View

13.

Doll M, Hein D . Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1. Anal Biochem. 2002; 301(2):328-32. DOI: 10.1006/abio.2001.5520. View

14.

Zhao B, Lee E, Yeoh P, Gong N . Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations. Pharmacogenetics. 1998; 8(4):299-304. DOI: 10.1097/00008571-199808000-00003. View

15.

Agrawal D, Gupta S, Agarwal D, Gupta O, Agarwal M . Role of GSTM1 and GSTT1 polymorphism: susceptibility to oral submucous fibrosis in the North Indian population. Oncology. 2011; 79(3-4):181-6. DOI: 10.1159/000318533. View

16.

Ramachandran S, Ramadas K, Hariharan R, Kumar R, Pillai M . Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 2005; 42(4):350-62. DOI: 10.1016/j.oraloncology.2005.08.010. View

17.

Wikman H, Bouchardy C, Mitrunen K, Dayer P, Benhamou S, Hirvonen A . Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers. Pharmacogenetics. 2000; 9(4):533-7. View

18.

Crow J . Eighty years ago: the beginnings of population genetics. Genetics. 1988; 119(3):473-6. PMC: 1203431. DOI: 10.1093/genetics/119.3.473. View

19.

Bell D, Badawi A, Lang N, Ilett K, Kadlubar F, Hirvonen A . Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res. 1995; 55(22):5226-9. View

20.

Kidd L, VanCleave T, Doll M, Srivastava D, Thacker B, Komolafe O . No association between variant N-acetyltransferase genes, cigarette smoking and Prostate Cancer susceptibility among men of African descent. Biomark Cancer. 2011; 2011(3):1-13. PMC: 3122269. DOI: 10.4137/BIC.S6111. View